BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28784131)

  • 21. Implementation of antiretroviral therapy guidelines for under-five children in Tanzania: translating recommendations into practice.
    Nuwagaba-Biribonwoha H; Wang C; Kilama B; Jowhar FK; Antelman G; Panya MF; Abrams EJ;
    J Int AIDS Soc; 2015; 18(1):20303. PubMed ID: 26690303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of a pediatric HIV treatment program in Maputo, Mozambique: a cohort study.
    Walter J; Molfino L; Moreno V; Edwards CG; Chissano M; Prieto A; Bocharnikova T; Antierens A; Lujan J
    Glob Health Action; 2015; 8():26652. PubMed ID: 26287397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
    Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
    J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART.
    Amanzi P; Michelo C; Simoonga C; Dambe R; Chongwe G
    Pan Afr Med J; 2016; 24():144. PubMed ID: 27642482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion and scale-up of HIV care and treatment services in four countries over ten years.
    Teasdale CA; Abrams EJ; Yuengling KA; Lamb MR; Wang C; Vitale M; Hawken M; Melaku Z; Nuwagaba-Biribonwoha H; El-Sadr WM
    PLoS One; 2020; 15(4):e0231667. PubMed ID: 32298331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid antiretroviral initiation among Thai youth living with HIV in the National AIDS programme in the era of treatment at any CD4 cell count: a national registry database study.
    Teeraananchai S; Kerr SJ; Khananuraksa P; Ruxrungtham K; Puthanakit T
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25574. PubMed ID: 32869537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful paediatric HIV treatment in rural primary care in Africa.
    Janssen N; Ndirangu J; Newell ML; Bland RM
    Arch Dis Child; 2010 Jun; 95(6):414-21. PubMed ID: 19880392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
    Siegfried N; Davies MA; Penazzato M; Muhe LM; Egger M
    Cochrane Database Syst Rev; 2013 Oct; 10(10):CD010309. PubMed ID: 24114324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persons living with HIV with advanced HIV disease: need for novel care models.
    Teasdale CA; Yuengling K; Preko P; Syowai M; Ndagije F; Rabkin M; Abrams EJ; El-Sadr WM
    J Int AIDS Soc; 2018 Dec; 21(12):e25210. PubMed ID: 30549245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini.
    Kerschberger B; Jobanputra K; Schomaker M; Kabore SM; Teck R; Mabhena E; Lukhele N; Rusch B; Boulle A; Ciglenecki I
    J Int AIDS Soc; 2019 Oct; 22(10):e25401. PubMed ID: 31647613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries.
    Fayorsey RN; Saito S; Carter RJ; Gusmao E; Frederix K; Koech-Keter E; Tene G; Panya M; Abrams EJ
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):e124-30. PubMed ID: 23337367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries.
    Eduardo E; Lamb MR; Kandula S; Howard A; Mugisha V; Kimanga D; Kilama B; El-Sadr W; Elul B
    PLoS One; 2014; 9(7):e103864. PubMed ID: 25075743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective linkage from point of HIV testing to care and treatment in Tanga region, Tanzania.
    Kayabu DE; Ngocho JS; Mmbaga BT
    PLoS One; 2018; 13(8):e0201644. PubMed ID: 30114244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.
    Mugglin C; Wandeler G; Estill J; Egger M; Bender N; Davies MA; Keiser O
    PLoS One; 2013; 8(2):e56446. PubMed ID: 23437135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of HIV-infected children seen in Western Kenya.
    Nyandiko WM; Mwangi A; Ayaya SO; Nabakwe EC; Tenge CN; Gisore PM; Vreeman RC
    East Afr Med J; 2009 Aug; 86(8):364-73. PubMed ID: 20575310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.
    McNairy ML; Lamb MR; Carter RJ; Fayorsey R; Tene G; Mutabazi V; Gusmao E; Panya M; Sheriff M; Abrams EJ;
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):e70-81. PubMed ID: 23111575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.